Telomir Pharmaceuticals, Inc.
TELO
$1.22
$0.032.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.88M | -9.22M | -10.41M | -11.25M | -16.08M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 0.00 |
| Total Other Non-Cash Items | 916.50K | 4.79M | 6.13M | 8.33M | 13.04M |
| Change in Net Operating Assets | 45.00K | -168.70K | 594.70K | -172.60K | -126.40K |
| Cash from Operations | -4.91M | -4.60M | -3.69M | -3.09M | -3.17M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 380.30K | 380.30K | 155.50K | -- | -132.40K |
| Total Debt Repaid | -243.90K | -177.40K | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 8.51M | 9.55M | 9.55M | 9.59M | 2.09M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 682.30K | -- | -- | 0.00 | 85.50K |
| Cash from Financing | 9.33M | 9.76M | 9.71M | 9.59M | 2.04M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.42M | 5.16M | 6.02M | 6.49M | -1.13M |